1
/
of
1
Retatrutide
Retatrutide
Regular price
£70.00 GBP
Regular price
Sale price
£70.00 GBP
Taxes included.
Quantity
Couldn't load pickup availability
Triple receptor agonist — GLP-1, GIP and glucagon — under clinical investigation.
Overview
Retatrutide is a novel triple agonist targeting GLP-1, GIP and glucagon receptors simultaneously, making it one of the most advanced metabolic research compounds currently available. It remains under clinical investigation and is not an approved medicine.
Research applications
- Simultaneous activation of three metabolic receptor systems
- Adipose tissue reduction in research models
- Insulin sensitivity markers
- Appetite regulation via central nervous system pathways
- Energy expenditure and hepatic fat oxidation
Mechanism of action
Binds GLP-1, GIP and glucagon receptors concurrently. GLP-1 and GIP activity influences insulin secretion and appetite signalling, while glucagon receptor activity increases energy expenditure and promotes hepatic fat oxidation — three levers rather than one.
Specifications
| Molecular weight | ~4.7 kDa |
| Purity | ≥98% (HPLC) |
| Form | Lyophilised powder |
| Storage | −20°C long term |
| Reconstitution | Bacteriostatic water |
| Origin | UK |
Research use only. Supplied strictly for in-vitro laboratory research. Not for human or animal consumption, and not for diagnostic or therapeutic use. To be handled only by qualified professionals. You must be 18 or over to purchase. Certificate of analysis available for every batch on request.
Share
